B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

D. L. Petersen, T. Krejsgaard, J. Berthelsen, S. Fredholm, A. Willerslev-Olsen, N. A. Sibbesen, C. M. Bonefeld, M. H. Andersen, C. Francavilla, J. V. Olsen, T. Hu, M. Zhang, M. A. Wasik, C. Geisler, A. Woetmann, N. Odum

Research output: Contribution to journal › Letter › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)'. Together they form a unique fingerprint.

Medicine and Dentistry